NO20052379D0 - Nye antitumorale forbindelser - Google Patents
Nye antitumorale forbindelserInfo
- Publication number
- NO20052379D0 NO20052379D0 NO20052379A NO20052379A NO20052379D0 NO 20052379 D0 NO20052379 D0 NO 20052379D0 NO 20052379 A NO20052379 A NO 20052379A NO 20052379 A NO20052379 A NO 20052379A NO 20052379 D0 NO20052379 D0 NO 20052379D0
- Authority
- NO
- Norway
- Prior art keywords
- antitumoral compounds
- new antitumoral
- new
- compounds
- kahalalide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB2002/004735 WO2003033012A1 (en) | 2001-10-19 | 2002-10-18 | Kahalalide compounds for use in cancer therapy |
| GBGB0304367.6A GB0304367D0 (en) | 2003-02-26 | 2003-02-26 | Methods for treating psoriasis |
| GB0314725A GB0314725D0 (en) | 2003-06-24 | 2003-06-24 | New antitumoral compounds |
| PCT/US2003/033207 WO2004035613A2 (en) | 2002-10-18 | 2003-10-20 | 4-methylhexanoic kahalaide f compound |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20052379D0 true NO20052379D0 (no) | 2005-05-13 |
| NO20052379L NO20052379L (no) | 2005-07-15 |
| NO333448B1 NO333448B1 (no) | 2013-06-10 |
Family
ID=35276268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052379A NO333448B1 (no) | 2002-10-18 | 2005-05-13 | Nye 4-metylheksansyre kahalalid F forbindelser, fremgangsmate for deres fremstilling, deres anvendelse for fremstilling av et medikament fortrinnsvis for behandling av kreft, farmasoytiskpreparat omfattende forbindelsene, og et sett som inneholder et farmasoytisk preparat omfattendeforbindelsene. |
Country Status (12)
| Country | Link |
|---|---|
| KR (2) | KR20110114690A (no) |
| AT (1) | ATE490975T1 (no) |
| AU (1) | AU2003285911B2 (no) |
| CY (1) | CY1111319T1 (no) |
| DE (1) | DE60335292D1 (no) |
| DK (1) | DK1572726T3 (no) |
| HK (1) | HK1082261A1 (no) |
| IL (1) | IL167724A (no) |
| NO (1) | NO333448B1 (no) |
| PL (1) | PL209129B1 (no) |
| PT (1) | PT1572726E (no) |
| SI (1) | SI1572726T1 (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0321066D0 (en) * | 2003-09-09 | 2003-10-08 | Pharma Mar Sau | New antitumoral compounds |
| GB0408958D0 (en) * | 2004-04-22 | 2004-05-26 | Pharma Mar Sa | Convergent synthesis for kahalalide compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9302046D0 (en) * | 1993-02-03 | 1993-03-24 | Pharma Mar Sa | Antiumoral compound-v |
| CN1568192A (zh) * | 2000-10-31 | 2005-01-19 | 法马马有限公司 | KahalalideF制剂 |
| WO2003033012A1 (en) * | 2001-10-19 | 2003-04-24 | Pharma Mar, S.A. | Kahalalide compounds for use in cancer therapy |
-
2003
- 2003-10-20 PT PT03779140T patent/PT1572726E/pt unknown
- 2003-10-20 DE DE60335292T patent/DE60335292D1/de not_active Expired - Lifetime
- 2003-10-20 AT AT03779140T patent/ATE490975T1/de active
- 2003-10-20 DK DK03779140.7T patent/DK1572726T3/da active
- 2003-10-20 PL PL377056A patent/PL209129B1/pl unknown
- 2003-10-20 KR KR1020117020121A patent/KR20110114690A/ko not_active Application Discontinuation
- 2003-10-20 AU AU2003285911A patent/AU2003285911B2/en not_active Ceased
- 2003-10-20 SI SI200331948T patent/SI1572726T1/sl unknown
- 2003-10-20 KR KR1020057006480A patent/KR101149095B1/ko not_active IP Right Cessation
-
2005
- 2005-03-29 IL IL167724A patent/IL167724A/en not_active IP Right Cessation
- 2005-05-13 NO NO20052379A patent/NO333448B1/no not_active IP Right Cessation
-
2006
- 2006-03-08 HK HK06102999.1A patent/HK1082261A1/xx not_active IP Right Cessation
-
2011
- 2011-03-08 CY CY20111100265T patent/CY1111319T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1572726E (pt) | 2011-02-14 |
| IL167724A (en) | 2012-01-31 |
| NO20052379L (no) | 2005-07-15 |
| ATE490975T1 (de) | 2010-12-15 |
| NO333448B1 (no) | 2013-06-10 |
| KR20050070056A (ko) | 2005-07-05 |
| HK1082261A1 (en) | 2006-06-02 |
| DK1572726T3 (da) | 2011-03-28 |
| PL209129B1 (pl) | 2011-07-29 |
| CY1111319T1 (el) | 2015-08-05 |
| PL377056A1 (pl) | 2006-01-23 |
| AU2003285911B2 (en) | 2009-11-19 |
| KR101149095B1 (ko) | 2012-05-30 |
| KR20110114690A (ko) | 2011-10-19 |
| SI1572726T1 (sl) | 2011-04-29 |
| AU2003285911A1 (en) | 2004-05-04 |
| DE60335292D1 (de) | 2011-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1091112A1 (en) | Compounds and methods for increasing neurogenesis | |
| UY28258A1 (es) | Tratamiento terapeutico | |
| NO20055741D0 (no) | Nye kjemiske forbindelser | |
| EA200400971A1 (ru) | Фторзамещенные циклоалканоиндолы, композиции, содержащие такие соединения, и способы лечения | |
| CY1112743T1 (el) | Στερεοϊσομερως εμπλουτισμενες ενωσεις 3-αμινοκαρβονυλ δικυκλοεπτενο πυριμιδινοδιαμινης και οι χρησεις τους | |
| BRPI0418251A (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais | |
| PA8525201A1 (es) | Tetrazolil-fenil acetamidas como activadores de la glucoquinasa | |
| EA200201214A1 (ru) | Замещенные тиоацетамиды | |
| MXPA04003796A (es) | Tioacetamidas sustituidas. | |
| CL2007002384A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis. | |
| BR0315644A (pt) | Piperazinil e diazapanil benzamidas e benzotioamidas | |
| PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
| ATE486915T1 (de) | Azeotrop-ähnliche zusammensetzung von 1,2-dichlor-3,3,3-trifluorpropen und fluorwasserstoff | |
| ATE549024T1 (de) | Chinazolin-kaliumkanalhemmer | |
| BR0209541A (pt) | Uso das imidazotriazinonas 2-fenil-substituìdas | |
| MXPA05004133A (es) | Nuevos compuestos antitumorales. | |
| DE60101559D1 (de) | Benutzung von comt-inhibitoren als analgetika | |
| EP1667976A4 (en) | Isoquinolinone POTASSIUM CHANNEL INHIBITORS | |
| BRPI0511125A (pt) | usos de ácido 5,6,7-triidroxieptanóico seus e análogos | |
| HUP0402165A2 (hu) | Nem neurotoxikus plazminogén aktiváló faktorok a szélhűdés kezelésére | |
| ECSP044971A (es) | Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson | |
| DE60316128D1 (de) | N-sulfonylurea-apoptosis-förderer | |
| NO20052379L (no) | Nye antitumorale forbindelser | |
| EA200200948A1 (ru) | Лечение псориаза | |
| EA200401032A1 (ru) | Антиинфарктные молекулы |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |